Aaron L Magno - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Aaron L Magno

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

JACC. Basic to Translational Science|March 7, 2020

SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal ProtectionLakshini Y Herat, Aaron L Magno, Caroline Rudnicka, et al.

Lancet (London, England)|October 4, 2015

Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trialElizabeth P Rakoczy, Chooi-May Lai, Aaron L Magno, et al.

Ebiomedicine|November 21, 2016

Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular DegenerationIan J Constable, Cora M Pierce, Chooi-May Lai, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

JACC. Basic to Translational Science|March 7, 2020

SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal ProtectionLakshini Y Herat, Aaron L Magno, Caroline Rudnicka, et al.

Lancet (London, England)|October 4, 2015

Ebiomedicine|November 21, 2016

Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular DegenerationIan J Constable, Cora M Pierce, Chooi-May Lai, et al.

Pageof 3